34 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares climbed 50.9% to $4.2550.
NeuroMetrix Stock Surges As Its Nerve Stimulator Scores FDA Breakthrough Designation For Fibromyalgia
NeuroMetrix Inc’s (NASDAQ:NURO) Quell device has received Breakthrough Designation from the FDA to treat fibromyalgia symptoms in adults. Fibromyalgia is a…
NeuroMetrix Says Receives FDA Breakthrough Device Designation For Treatment Of Fibromyalgia With Its Wearable Neurostimulation Technology
NeuroMetrix, Inc. (NASDAQ:NURO) today announced that its Quell® device has received Breakthrough Designation from the U.S. Food and Drug Administration (FDA) for treating the symptoms of fibromyalgia in
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears, and exerted negative pressure on stocks.
There were very few stock-specific catalysts, barring a few preannouncements, stock offerings, and a slew of initial public offerings.
NeuroMetrix Entered Termination Agreement With GSK Consumer Healthcare S.A. In Which Co. Terminated Development And Services Agreement For Quell; GASK Transferred To NeuroMetrix All Rights, Title And Interest In Quell Related To Markets Outside US
On June 30, 2021 NeuroMetrix, Inc. (the “Company” or “NeuroMetrix”) entered into a Termination Agreement with GSK Consumer Healthcare S.A. (formerly known as Novartis Consumer Health S.A.), a
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
Zosano Pharma (NASDAQ:ZSAN) stock rose 22.29% to $0.91 during Wednesday's after-market session. This security traded at a volume of 1.8 million shares come close, making up 69.15% of its average volume over the last 100 days. The company's market cap stands at $97.1 million.
Earnings Scheduled For April 22, 2021
Companies Reporting Before The Bell
• Republic First Bancorp (NASDAQ:FRBK) is estimated to report quarterly earnings at $0.05 per share on revenue of $36.85 million.
70 Biggest Movers From Yesterday
Gainers Genprex, Inc. (NASDAQ:GNPX) shares surged 64.4% to close at $1.89 on Wednesday after climbing 219.44% on Tuesday.…